Profil拥有制造包括无菌剂型在内的试验用药品(IMP)的完整GMP制造许可。
 
                            
              
                           |  ISO 13485:2016 
 |  ISO 9001:2015 
 | 
 
                            
                            
                            
Marquard J. et al., 2015. Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment. Nature Medicine 21, 363–372 (2015).